KAPA

Kairos Pharma, Ltd.

Insider Trades

NameValueActionPriceCurrent Price
Murali RamachandranVP Of Research And Development
$318200 shares
BuyNov 25, 2024
$1.59
--
Samuelson DougChief Financial Officer
$3.8k2.5k shares
BuyNov 22, 2024
$1.50
--
Yu John SDirector, 10 Percent Owner, Officer: CEO And Chairman
$5.8k4k shares
BuyNov 20, 2024
$1.44
--

News

businesswire.comKairos Pharma Recaps Important Acquisitions and Details Plans for the Balance of 2026 in Letter to Shareholdersbusinesswire.comJun 4businesswire.comKairos Pharma Receives GHP Magazine's Healthcare & Pharmaceutical Awardbusinesswire.comMay 14newsfilecorp.comKairos Pharma, Ltd. to Present at the LD Micro Invitational XVInewsfilecorp.comMay 13businesswire.comKairos Pharma, Ltd. Sets Annual Meeting of Shareholder Date and Provides Update on Its Annual Filingsbusinesswire.comMay 8globenewswire.comKAPA Investors Have Opportunity to Join Kairos Pharma, Ltd. Fraud Investigation with the Schall Law Firmglobenewswire.comApr 28